αž‘αžΈαž•αŸ’αžŸαžΆαžš
Biomarin Pharmaceutical Inc
61.80$
αž€αŸ’αžšαŸ„αž™αž˜αŸ‰αŸ„αž„αŸ–
61.80$
(0.00%)0.00
αž”αžΆαž“αž”αž·αž‘αŸ– 27 αž˜αž€αžšαžΆ, 4:11:37 PM αž˜αŸ‰αŸ„αž„β€‹αžŸαž€αž› -5 · USD · NASDAQ · αžŸαŸαž…αž€αŸ’αžŠαžΈαž”αŸ’αžšαž€αžΆαžŸαž˜αž·αž“αž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœ
αž—αžΆαž‚β€‹αž αŸŠαž»αž“αž˜αžΌαž›αž”αžαŸ’αžšαžŠαŸ‚αž›αž”αžΆαž“αž…αž»αŸ‡αž”αž‰αŸ’αž‡αžΈαž“αŸ… αž’αžΆαž˜αŸαžšαž·αž€αž˜αžΆαž“αž‘αžΈαžŸαŸ’αž“αžΆαž€αŸ‹αž€αžΆαžšαž€αžŽαŸ’αžŠαžΆαž›αž“αŸ… αž’αžΆαž˜αŸαžšαž·αž€
αž”αž·αž‘αž–αžΈαž˜αž»αž“
61.73$
αž…αž“αŸ’αž›αŸ„αŸ‡αžαŸ’αž„αŸƒαž“αŸαŸ‡
61.23$ - 63.15$
αž…αž“αŸ’αž›αŸ„αŸ‡αž˜αž½αž™αž†αŸ’αž“αžΆαŸ†αž…αž»αž„αž€αŸ’αžšαŸ„αž™
60.63$ - 94.85$
αžŠαžΎαž˜β€‹αž‘αž»αž“β€‹αž‘αžΈαž•αŸ’αžŸαžΆαžš
11.78Β αž”αŸŠαžΈαž›αžΆαž“ USD
αž‘αŸ†αž αŸ†αž‡αž½αž‰αžŠαžΌαžšαž˜αž’αŸ’αž™αž˜
1.53Β αž›αžΆαž“
αž’αž“αž»αž”αžΆαž P/E
37.17
αž‘αž·αž“αŸ’αž“αž•αž›β€‹αž—αžΆαž‚αž›αžΆαž—
-
αž€αžΆαžšαžŠαŸ„αŸ‡αžŠαžΌαžšαž…αž˜αŸ’αž”αž„
NASDAQ
αž αž·αžšαž‰αŸ’αž‰αžœαžαŸ’αžαž»
αžšαž”αžΆαž™αž€αžΆαžšαžŽαŸαž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
(USD)αž€αž‰αŸ’αž‰αžΆ 2024αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›
745.74Β αž›αžΆαž“28.28%
αž…αŸ†αžŽαžΆαž™αž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
443.39Β αž›αžΆαž“4.88%
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
106.08Β αž›αžΆαž“162.72%
αž”αŸ’αžšαžΆαž€αŸ‹αž…αŸ†αžŽαŸαž‰αžŸαž»αž‘αŸ’αž’
14.22104.60%
β€‹αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’β€‹αž€αŸ’αž“αž»αž„αž˜αž½αž™αž—αžΆαž‚αž αŸŠαž»αž“
0.9197.83%
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’αž˜αž»αž“αž€αžΆαžšαž”αŸ’αžšαžΆαž€αŸ‹ αž–αž“αŸ’αž’ αž€αžΆαžšαžšαŸ†αž›αžŸαŸ‹ αž“αž·αž„αž€αžΆαžšαž€αžΆαžαŸ‹αžšαŸ†αž›αžŸαŸ‹
132.90Β αž›αžΆαž“136.43%
αž’αžαŸ’αžšαžΆαž–αž“αŸ’αž’αžŠαŸ‚αž›αž˜αžΆαž“αž”αŸ’αžšαžŸαž·αž‘αŸ’αž’αž—αžΆαž–
21.10%β€”
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
(USD)αž€αž‰αŸ’αž‰αžΆ 2024αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹ αž“αž·αž„αž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚αžšαž™αŸˆαž–αŸαž›αžαŸ’αž›αžΈ
930.44Β αž›αžΆαž“-17.36%
αž‘αŸ’αžšαž–αŸ’αž™αžŸαžšαž»αž”
6.85Β αž”αŸŠαžΈαž›αžΆαž“1.38%
αž€αžΆαžšαž‘αž‘αž½αž›αžαž»αžŸαžαŸ’αžšαžΌαžœαžŸαžšαž»αž”
1.44Β αž”αŸŠαžΈαž›αžΆαž“-22.75%
αž˜αžΌαž›β€‹αž’αž“αžŸαžšαž»αž”
5.41Β αž”αŸŠαžΈαž›αžΆαž“β€”
αž—αžΆαž‚αž αŸŠαž»αž“β€‹αž˜αž·αž“β€‹αž‘αžΆαž“αŸ‹αž”αžΆαž“αž”αž„αŸ‹
190.58Β αž›αžΆαž“β€”
αžαž˜αŸ’αž›αŸƒαž’αŸ€αž”αž“αžΉαž„αžŸαŸ€αžœαž—αŸ…
2.17β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαž‘αŸ’αžšαž–αŸ’αž™
4.09%β€”
αž•αž›αž…αŸ†αžŽαŸαž‰αž›αžΎαžŠαžΎαž˜αž‘αž»αž“
4.59%β€”
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
(USD)αž€αž‰αŸ’αž‰αžΆ 2024αž€αžΆαžšαž•αŸ’αž›αžΆαžŸαŸ‹αž”αŸ’αžŠαžΌαžšαžαžΆαž˜β€‹αž†αŸ’αž“αžΆαŸ†
αž…αŸ†αžŽαžΌαž›αžŸαž»αž‘αŸ’αž’
106.08Β αž›αžΆαž“162.72%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž”αŸ’αžšαžαž·αž”αžαŸ’αžαž·αž€αžΆαžš
221.48Β αž›αžΆαž“63.28%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž€αžΆαžšαžœαž·αž“αž·αž™αŸ„αž‚
-16.16Β αž›αžΆαž“64.72%
αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž–αžΈαž αž·αžšαž‰αŸ’αž‰β€‹αž”αŸ’αž”αž‘αžΆαž“
-499.12Β αž›αžΆαž“-63,240.74%
αž€αžΆαžšαž”αŸ’αžšαŸ‚αž”αŸ’αžšαž½αž›β€‹αžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αžŸαž»αž‘αŸ’αž’
-296.70Β αž›αžΆαž“-425.93%
αž›αŸ†αž αžΌαžšαžŸαžΆαž…αŸ‹αž”αŸ’αžšαžΆαž€αŸ‹αž‘αŸ†αž“αŸαžš
165.57Β αž›αžΆαž“86.81%
αž’αŸ†αž–αžΈ
BioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies. BioMarin was the first company to provide therapeutics for mucopolysaccharidosis type I, by manufacturing laronidase. BioMarin was also the first company to provide therapeutics for phenylketonuria. Over the years, BioMarin has been criticised for drug pricing and for specific instances of denying access to drugs in clinical trials. Wikipedia
αž”αžΆαž“αž”αž„αŸ’αž€αžΎαžαž‘αžΎαž„
αž˜αžΈαž“αžΆ 1997
αžαŸ†αž”αž“αŸ‹β€‹αž”αžŽαŸ’αžŠαžΆαž‰
αž”αž»αž‚αŸ’αž‚αž›αž·αž€
3,401
αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αž…αŸ’αžšαžΎαž“αž‘αŸ€αž
αž€αŸαž˜αžΆαž“β€‹αž’αŸ’αž“αž€β€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€β€‹αžŠαŸ‚αžš
αžŸαŸ’αžœαŸ‚αž„αžšαž€
αžŸαž˜αŸ’αž’αžΆαžβ€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž”αž·αž‘β€‹αž€αžΆαžšβ€‹αžŸαŸ’αžœαŸ‚αž„αžšαž€
αž€αž˜αŸ’αž˜αžœαž·αž’αžΈ Google
αž˜αŸ‰αžΊαž“αž»αž™αžŠαžΎαž˜